Zacks: BioHiTech Global Inc (NASDAQ:BHTG) Given $3.63 Average Price Target by Brokerages

Share on StockTwits

Shares of BioHiTech Global Inc (NASDAQ:BHTG) have been given an average broker rating score of 1.50 (Buy) from the two analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation and one has given a strong buy recommendation to the company.

Brokerages have set a 12-month consensus price target of $3.63 for the company, according to Zacks. Zacks has also given BioHiTech Global an industry rank of 99 out of 255 based on the ratings given to its competitors.

Separately, Maxim Group reissued a “buy” rating and issued a $2.75 price target on shares of BioHiTech Global in a research report on Thursday, October 17th.

In related news, Director James D. Chambers bought 17,000 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was purchased at an average cost of $1.79 per share, with a total value of $30,430.00. Over the last quarter, insiders purchased 24,000 shares of company stock valued at $42,486. 41.90% of the stock is currently owned by company insiders.

A number of large investors have recently modified their holdings of the stock. Susquehanna International Group LLP purchased a new position in BioHiTech Global in the second quarter worth approximately $25,000. Vanguard Group Inc. grew its holdings in BioHiTech Global by 38.4% during the 2nd quarter. Vanguard Group Inc. now owns 85,352 shares of the company’s stock worth $152,000 after acquiring an additional 23,701 shares in the last quarter. Finally, Gabelli Funds LLC purchased a new stake in shares of BioHiTech Global in the 3rd quarter valued at approximately $44,000. 7.76% of the stock is currently owned by hedge funds and other institutional investors.

BHTG traded up $0.01 during trading hours on Tuesday, hitting $1.66. 5,948 shares of the company’s stock were exchanged, compared to its average volume of 10,737. BioHiTech Global has a 12-month low of $1.56 and a 12-month high of $3.30. The company has a debt-to-equity ratio of 7.41, a current ratio of 0.74 and a quick ratio of 0.69. The firm has a 50 day moving average of $1.75 and a 200 day moving average of $1.95.

About BioHiTech Global

BioHiTech Global, Inc provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste.

Featured Story: Cost of Equity For A Business, Investors

Get a free copy of the Zacks research report on BioHiTech Global (BHTG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for BioHiTech Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHiTech Global and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.